person

Anders Ö.

Country
Sweden
Department
Department of Women's and Children's Health

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
14
Sites with multiple studies

Has run more than one trial at 14 of 121 partner sites.

Specializations

Neuro-Oncology Focus

This investigator specializes in the treatment of medulloblastoma, demonstrating particular expertise in pediatric and adolescent brain tumors. Their research concentrates on developing therapeutic strategies for different risk profiles of this condition.

  • Standard-risk medulloblastoma management
  • High-risk tumor interventions
  • Biological risk profiling

Their work encompasses targeted therapeutic approaches based on distinct biological characteristics of brain tumors.

Radiation Oncology

The investigator's expertise extends to specialized neuraxis irradiation protocols, incorporating various radiation dosing strategies. Their work involves implementing precise radiation therapy approaches customized to specific risk groups.

  • Customized radiation protocols
  • Combined modality treatment
  • Risk-adapted radiation therapy

Their approach integrates radiation therapy with other treatment modalities for optimal therapeutic outcomes.

Molecular Oncology

The investigator focuses on molecular profiling in brain tumors, particularly examining TP53 mutations and their impact on treatment strategies. Their work involves analyzing specific genetic markers to guide therapeutic decisions.

  • Genetic mutation analysis
  • Molecular risk stratification
  • Personalized treatment approaches

Their research emphasizes the importance of molecular characteristics in treatment selection.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.